This opportunity is no longer accepting applications.
grant CBD244-P001

Host Directed Therapeutics for treatment for viral disease \xe2\x80\x93 Open Topic

The grant opportunity is focused on developing host-directed therapeutics (HDTs) for viral infections, specifically targeting human host factors or pathways to treat or prevent infections. Unlike direct-acting antivirals, HDTs aim to combat drug-resistant viruses and work against multiple virus serotypes or genotypes. The goal is to create therapeutics that can address gaps in existing treatme…

OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Biotechnology\n\nOBJECTIVE: The goal of this SBIR is to develop and demonstrate efficacy of broadly active host directed therapeutics to be used as treatment, either as sole agents or as combination agents, in the event of disease or as prophylactic me…

Funding Source

Agency: Office for Chemical and Biological Defense

Dates

Open for Submission: July 23, 2024
Application Window Closes: September 24, 2024
Opportunity Released: October 3, 2023

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.